Table 1.
Patient characteristics.
| AAD (n = 25) | TAVI (n = 25) | p | ||
|---|---|---|---|---|
| Age (years) | 60 (53–67) | 76 (71–80) | <0.001 | |
| Sex | 15 (60.0%) | 15 (60.0%) | 1.000 | |
| Body mass index (kg/m2) | 28.7 (24.1–30.8) | 27.4 (25.2–29.8) | 0.87 | |
| Diabetes mellitus type 2 | 3 (12.0%) | 6 (24.0%) | 0.27 | |
| Hypertension | 23 (92.0%) | 23 (92.0%) | 1.00 | |
| Atrial fibrillation | 0 (0%) | 0 (0%) | 1.00 | |
| Chronic heart failure | 1 (4.0%) | 4 (16.0%) | 0.16 | |
| Smoker | Active | 17 (68.0%) | 11 (44.0%) | 0.20 |
| Previous | 7 (28.0%) | 11 (44.0%) | ||
| Tamponade | 5 (20.0%) | 1 (4.0%) | 0.08 | |
| Ejection fraction (%) | 40 (40–48) | 48 (40–55) | 0.07 | |
| Parts of aorta involved | ||||
| Ascending | 5 (20.0%) | |||
| Ascending + arch | 12 (48.0%) | |||
| Ascending + arch + thoracic + abdominal | 3 (12.0%) | |||
| Thoracic + abdominal | 5 (20.0%) | |||
| Surgery time (min) | 320 (290–450) | |||
| Cardiopulmonary bypass time (min) | 200 (158–280) | |||
| Aortic cross-clamp time (min) | 128 (110–162) | |||
| Distal hypothermic circulatory arrest time (min) | 35 (30–40) | |||
| Prosthesis length 100 | 12 (48%) | |||
| Prosthesis length 150 | 13 (52%) | |||
| Blood cell transfusion | 25 (100%) | |||
| 30-day mortality | 1 (4%) | |||
| Hospitalization time | 20 (15-26) | |||